These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26026863)

  • 41. LGE-CMR-derived texture features reflect poor prognosis in hypertrophic cardiomyopathy patients with systolic dysfunction: preliminary results.
    Cheng S; Fang M; Cui C; Chen X; Yin G; Prasad SK; Dong D; Tian J; Zhao S
    Eur Radiol; 2018 Nov; 28(11):4615-4624. PubMed ID: 29728817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy.
    Peteiro J; Fernandez X; Bouzas-Mosquera A; Monserrat L; Méndez C; Rodriguez-Garcia E; Soler R; Couto D; Castro-Beiras A
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):423-32. PubMed ID: 25428944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies.
    Peretto G; Sala S; Lazzeroni D; Palmisano A; Gigli L; Esposito A; De Cobelli F; Camici PG; Mazzone P; Basso C; Della Bella P
    Heart Lung Circ; 2020 Sep; 29(9):1356-1365. PubMed ID: 32299760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
    Chaowu Y; Shihua Z; Jian L; Li L; Wei F
    Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Chen X; Zhao S; Zhao T; Lu M; Yin G; Jiang S; Prasad S
    Eur J Radiol; 2014 Feb; 83(2):297-302. PubMed ID: 24332848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
    Hollowell M; Banno J; Marsy D; Shrestha N; Tan J; McNamara R; Decker J; Albano A; Franey L; Abdallah W; Loyaga-Rendon R; Chalfoun N; Fermin D
    Int J Cardiol; 2024 Sep; 411():132263. PubMed ID: 38878873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incremental value of late gadolinium enhancement for management of patients with hypertrophic cardiomyopathy.
    Greulich S; Schumm J; Grün S; Bruder O; Sechtem U; Mahrholdt H
    Am J Cardiol; 2012 Oct; 110(8):1207-12. PubMed ID: 22762717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of apical subtype of hypertrophic cardiomyopathy using cardiac magnetic resonance imaging with gadolinium enhancement.
    Kebed KY; Al Adham RI; Bishu K; Askew JW; Klarich KW; Araoz PA; Foley TA; Glockner JF; Nishimura RA; Anavekar NS
    Am J Cardiol; 2014 Sep; 114(5):777-82. PubMed ID: 25037678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy.
    Fattori R; Biagini E; Lorenzini M; Buttazzi K; Lovato L; Rapezzi C
    Am J Cardiol; 2010 Jun; 105(11):1592-6. PubMed ID: 20494668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
    Petryka-Mazurkiewicz J; Ziolkowska L; Mazurkiewicz Ł; Kowalczyk-Domagała M; Boruc A; Śpiewak M; Marczak M; Brzezinska-Rajszys G
    PLoS One; 2021; 16(3):e0248725. PubMed ID: 33735278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delay enhancement patterns in apical hypertrophic cardiomyopathy by phase-sensitive inversion recovery sequence.
    Guo ZY; Chen J; Liang QZ; Liao HY; Fu SX; Tang QY; Chen CX; Han XJ; Gao F
    Asian Pac J Trop Med; 2012 Oct; 5(10):828-30. PubMed ID: 23043925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Nagata Y; Teramoto R; Fujino N; Nomura A; Tada H; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M; Hayashi K
    Am J Cardiol; 2016 Feb; 117(3):443-9. PubMed ID: 26705881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.
    Rodriguez-Granillo GA; Deviggiano A; Capunay C; Zan MC; Carrascosa P
    Arq Bras Cardiol; 2016 Jul; 107(1):48-54. PubMed ID: 27305110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationships between cardiac magnetic resonance imaging abnormalities in the inter-ventricular septum and Selvester QRS scoring criteria for anterior-septal myocardial infarction in patients with right ventricular volume overload.
    Siddiqui AM; Samad Z; Crowley AL; Hakacova N; Harrison JK; Wagner GS
    J Electrocardiol; 2013; 46(3):256-62. PubMed ID: 23562751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Scott PA; Morgan JM; Carroll N; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):324-30. PubMed ID: 21493964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?
    Bravo PE; Luo HC; Pozios I; Zimmerman SL; Corona-Villalobos CP; Sorensen L; Kamel IR; Bluemke DA; Wahl RL; Abraham MR; Abraham TP
    Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):293-300. PubMed ID: 26077330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
    Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
    Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
    Spiewak M; Malek LA; Misko J; Chojnowska L; Milosz B; Klopotowski M; Petryka J; Dabrowski M; Kepka C; Ruzyllo W
    Eur J Radiol; 2010 Jun; 74(3):e149-53. PubMed ID: 19523780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.